Wolverine Trading
CLVS

Wolverine Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Wolverine Trading’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-45,133
Closed -$77K – 5640
2022
Q2 		$77K Buy
+45,133
New +$66.6K ﹤0.01% 3927
2021
Q4 		– Sell
-28,367
Closed -$105K – 7243
2021
Q3 		$128K Buy
28,367
+6,528
+30% +$31.4K ﹤0.01% 5644
2021
Q2 		$128K Buy
21,839
+7,679
+54% +$45K ﹤0.01% 5281
2021
Q1 		$96K Sell
14,160
-7,805
-36% -$52.3K ﹤0.01% 5450
2020
Q4 		$108K Sell
21,965
-1,297
-6% -$6.56K ﹤0.01% 4448
2020
Q3 		$138K Buy
+23,262
New +$139K ﹤0.01% 4012
2019
Q4 		– Sell
-17,702
Closed -$71K – 5405
2019
Q3 		$71K Buy
17,702
+3,977
+29% +$32.2K ﹤0.01% 3960
2019
Q2 		$204K Buy
13,725
+5,230
+62% +$94.5K ﹤0.01% 3703
2019
Q1 		$211K Sell
8,495
-25,495
-75% -$639K ﹤0.01% 3768
2018
Q4 		$611K Buy
+33,990
New +$695K ﹤0.01% 2451
2018
Q3 		– Sell
-11,608
Closed -$449K – 6167
2018
Q2 		$613K Hold
11,608
– – ﹤0.01% 2816
2018
Q1 		$613K Sell
11,608
-31,340
-73% -$1.83M ﹤0.01% 2816
2017
Q4 		$2.92M Sell
42,948
-30,292
-41% -$2.12M 0.01% 1237
2017
Q3 		$6.04M Buy
73,240
+932
+1% +$73.9K 0.02% 662
2017
Q2 		$6.65M Buy
72,308
+38,197
+112% +$2.34M 0.03% 537
2017
Q1 		$2.14M Buy
+34,111
New +$2.07M 0.01% 1142
2016
Q3 		– Sell
-15,957
Closed -$342K – 5257
2016
Q2 		$240K Buy
+15,957
New +$233K ﹤0.01% 3060

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Wolverine Trading's CLVS Position: Q3 2022 in Review

Wolverine Trading sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 45,133 shares — an estimated $77K sold.

Wolverine Trading first reported a position in CLVS in Q2 2016 and held it in 17 quarters. The position peaked at $6.65M in Q2 2017. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

  • Wolverine Trading reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
  • Wolverine Trading sold 45,133 Clovis Oncology, Inc. shares in Q3 2022, an estimated $77K.
  • Wolverine Trading first reported a position in Clovis Oncology, Inc. in Q2 2016 and held it in 17 quarters.
  • Wolverine Trading's Clovis Oncology, Inc. position peaked at $6.65M in Q2 2017.
  • 103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Wolverine Trading's 13F filing for Q3 2022, filed 14 Nov 2022.